Catheter Precision (VTAK) EBIT Margin (2017 - 2026)

Catheter Precision (VTAK) has 10 years of EBIT Margin data on file, last reported at 536.57% in Q1 2026.

• On a quarterly basis, EBIT Margin rose 196343.0% year-over-year to 536.57% in Q1 2026; TTM through Mar 2026 was 1794.77%, a 74203.0% increase from a year earlier, with the FY2025 full-year figure at 2581.56%, up 9534.0% from the prior year.
• EBIT Margin for Q1 2026 stood at 536.57%, up from 4143.28% in the prior quarter.
• Over the last five years, EBIT Margin for VTAK reached as high as 536.57% in Q1 2026 and fell as low as 169200.0% in Q2 2022.
• Historically, EBIT Margin has averaged 22738.52% across 5 years, with a median of 2921.51% in 2024.
• Across the five-year window, EBIT Margin plunged 16847940 bps in 2022 and jumped 16262917 bps in 2023, its largest moves.
• Year by year, EBIT Margin stood at 169200.0% in 2022, then surged by 99 bps to 2028.91% in 2023, then retreated by 1 bps to 2047.65% in 2024, then plunged by 102 bps to 4143.28% in 2025, then soared by 87 bps to 536.57% in 2026.
• Per Business Quant data, the three most recent EBIT Margin figures were 536.57% in Q1 2026, 4143.28% in Q4 2025, and 1336.73% in Q3 2025.